IMV Inc IMVIF

RE:RE:RE:DLBCL trial

[Jthom376]

I expect nothing as a way of preventing further disappointment :). But the following was stated by TC... doubt we get that much detail. 

Thom Calandra

 

@thomcalandra

·

Mar 17

 

Investors will await March 31 '21 deadline, stated by

@imv_inc

today, for cash, royalty, other figures in a big pharma and-or institutional pact re: #DLBCL lymphoma (MAV and Keytruda). $IMV sold off today -- As an investor, I hope we see a financial collaboration by March 31. TC